Ability of the clinician and patient to predict the outcome of mifepristone and misoprostol medical abortion
- 1 October 2004
- journal article
- clinical trial
- Published by Elsevier BV in Contraception
- Vol. 70 (4), 313-317
- https://doi.org/10.1016/j.contraception.2004.04.005
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- A Randomized Comparison of Misoprostol 6 to 8 Hours Versus 24 Hours After Mifepristone for AbortionObstetrics & Gynecology, 2004
- Mifepristone and misoprostol and methotrexate/misoprostol in clinical practice for abortionAmerican Journal of Obstetrics and Gynecology, 2003
- Mifepristone-misoprostol abortion: a trial in rural and urban Maharashtra, IndiaContraception, 2002
- Clinicians’ perception of sonogram indication for mifepristone abortion up to 63 daysContraception, 2002
- Could American women use mifepristone-misoprostol pills safely with less medical supervision?Contraception, 2002
- Mifepristone followed on the same day by vaginal misoprostol for early abortionContraception, 2001
- Can women in less-developed countries use a simplified medical abortion regimen?The Lancet, 2001
- The roles of clinical assessment, human chorionic gonadotropin assays, and ultrasonography in medical abortion practiceAmerican Journal of Obstetrics and Gynecology, 2000
- Acceptability and Feasibility of Early Pregnancy Termination by Mifepristone-Misoprostol: Results of a Large Multicenter Trial in the United StatesArchives of Family Medicine, 1998
- Methotrexate and misoprostol vs misoprostol alone for early abortion. A randomized controlled trialPublished by American Medical Association (AMA) ,1994